These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 12894872)

  • 1. Immunosuppressive agents and cytomegalovirus infection.
    Tanaka K
    Arch Immunol Ther Exp (Warsz); 2003; 51(3):179-84. PubMed ID: 12894872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levels of CMV specific CD4 T cells are dynamic and correlate with CMV viremia after allogeneic stem cell transplantation.
    Widmann T; Sester U; Gärtner BC; Schubert J; Pfreundschuh M; Köhler H; Sester M
    PLoS One; 2008; 3(11):e3634. PubMed ID: 18982061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring cytomegalovirus IE-1 and pp65-specific CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation may identify patients at risk for recurrent CMV reactivations.
    Gratama JW; Brooimans RA; van der Holt B; Sintnicolaas K; van Doornum G; Niesters HG; Löwenberg B; Cornelissen JJ
    Cytometry B Clin Cytom; 2008 Jul; 74(4):211-20. PubMed ID: 18454493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytomegalovirus infection and disease in the new era of immunosuppression following solid organ transplantation.
    Fisher RA
    Transpl Infect Dis; 2009 Jun; 11(3):195-202. PubMed ID: 19228345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease.
    Tu W; Potena L; Stepick-Biek P; Liu L; Dionis KY; Luikart H; Fearon WF; Holmes TH; Chin C; Cooke JP; Valantine HA; Mocarski ES; Lewis DB
    Circulation; 2006 Oct; 114(15):1608-15. PubMed ID: 17015794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectivity of a T-cell-adapted induction therapy with anti-thymocyte globulin (Sangstat).
    Koch A; Daniel V; Dengler TJ; Schnabel PA; Hagl S; Sack FU
    J Heart Lung Transplant; 2005 Jun; 24(6):708-13. PubMed ID: 15949731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function.
    Nickel P; Bold G; Presber F; Biti D; Babel N; Kreutzer S; Pratschke J; Schönemann C; Kern F; Volk HD; Reinke P
    Transpl Immunol; 2009 Mar; 20(4):238-42. PubMed ID: 19032982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Properties of CD4(+) T cells in human cytomegalovirus infection.
    Gamadia LE; Rentenaar RJ; van Lier RA; ten Berge IJ
    Hum Immunol; 2004 May; 65(5):486-92. PubMed ID: 15172448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological monitoring of calcineurin inhibitors for predicting cytomegalovirus infection in kidney transplant recipients.
    Couzi L; Thiébaut R; Carron JC; Moreau JF; Merville P; Taupin JL
    Transplantation; 2008 Oct; 86(8):1060-7. PubMed ID: 18946343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors for persistent cytomegalovirus reactivation after T-cell-depleted allogeneic hematopoietic stem cell transplantation.
    Almyroudis NG; Jakubowski A; Jaffe D; Sepkowitz K; Pamer E; O'Reilly RJ; Papanicolaou GA
    Transpl Infect Dis; 2007 Dec; 9(4):286-94. PubMed ID: 17511819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection.
    Lilleri D; Fornara C; Chiesa A; Caldera D; Alessandrino EP; Gerna G
    Haematologica; 2008 Feb; 93(2):248-56. PubMed ID: 18245650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infectious complications in three double hand recipients: experience from a single center.
    Bonatti H; Brandacher G; Margreiter R; Schneeberger S
    Transplant Proc; 2009 Mar; 41(2):517-20. PubMed ID: 19328916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen-specific T cell responses induced by Towne cytomegalovirus (CMV) vaccine in CMV-seronegative vaccine recipients.
    Jacobson MA; Sinclair E; Bredt B; Agrillo L; Black D; Epling CL; Carvidi A; Ho T; Bains R; Adler SP
    J Clin Virol; 2006 Mar; 35(3):332-7. PubMed ID: 16387547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving outcomes for solid-organ transplant recipients at risk from cytomegalovirus infection: late-onset disease and indirect consequences.
    Legendre C; Pascual M
    Clin Infect Dis; 2008 Mar; 46(5):732-40. PubMed ID: 18220478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunology of cytomegalovirus: immunosuppressive effects during infections.
    Ho M
    Birth Defects Orig Artic Ser; 1984; 20(1):131-47. PubMed ID: 6203569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitation of cytomegalovirus DNA by the polymerase chain reaction as a predictor of disease in solid organ transplantation.
    Ghisetti V; Barbui A; Franchello A; Varetto S; Pittaluga F; Bobbio M; Salizzoni M; Marchiaro G
    J Med Virol; 2004 Jun; 73(2):223-9. PubMed ID: 15122796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease.
    Bronke C; Palmer NM; Jansen CA; Westerlaken GH; Polstra AM; Reiss P; Bakker M; Miedema F; Tesselaar K; van Baarle D
    J Infect Dis; 2005 Mar; 191(6):873-80. PubMed ID: 15717261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical aspects of CMV infection after stem cell transplantation.
    Hebart H; Einsele H
    Hum Immunol; 2004 May; 65(5):432-6. PubMed ID: 15172442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients at high risk for CMV infection and disease show delayed CD8+ T-cell immune recovery after allogeneic stem cell transplantation.
    Ganepola S; Gentilini C; Hilbers U; Lange T; Rieger K; Hofmann J; Maier M; Liebert UG; Niederwieser D; Engelmann E; Heilbronn R; Thiel E; Uharek L
    Bone Marrow Transplant; 2007 Mar; 39(5):293-9. PubMed ID: 17262060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular reactivation of MCMV after immunosuppression of latently infected BALB/c mice.
    Zhang M; Xin H; Duan Y; Atherton SS
    Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):252-8. PubMed ID: 15623781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.